NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE:BMY) will take part in the Evercore ISI Biopharma Conference on Wednesday, November 29, 2017, in Boston. Fouad Namouni, senior vice president, head of Oncology Development, will answer questions about the company at 11:45 a.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171122005003/en/

Source: Bristol-Myers Squibb Company